La description
[Product
Name]
COV*9/ FluA/ FluB
Antigen Combo Rapid Test Kit (Colloidal Gold
Method)
Â
[Packing
Specifications]
1 Test/box;2 Test/box;5
Test/box;*5 Test/box
Â
[Intended
Use]
The kit is an in vitro
immunochromatographic assay for the qualitative detection of
Cov*9, Influenza A and Influenza B virus
antigens in human nasopharyngeal, oropharyngeal swab, and salvia
samples.
Â
Cov*9 is an acute
respiratory infectious disease that humans are easily infected
with. According to current epidemiological
investigations, the incubation period is 1 to *4 days, mostly 3
to 7 days. The main symptoms are: fever, fatigue, dry
cough, in a few cases can appear nasal congestion, sore throat,
myalgia and diarrhea. Influenza, often called
"the flu," is caused by the influenza virus. It is a highly
contagious viral infection of the respiratory tract that
can be spread by coughing or sneezing. Influenza outbreaks occur
every fall and winter. There are
influenza A, B and C viruses. Influenza A viruses are more
prevalent than influenza B and Cand causes more severe
illness.
Â
Cov*9 infection and
Influenza virus infection have similar symptoms, such as fever,
cough, etc. This kit can simultaneously detect
the antigens of the three viruses and provides an easy workflow,
short turnaround time, and rapid diagnosis of
Cov*9, Influenza A and influenza B virus infections using
nasopharyngeal, oropharyngeal swab or salvia
samples.
Â
[Detection
Principle]
The kit is an
immunochromatographic assay,based on double antibody sandwich
method to detect Cov*9 and Influenza A/B virus
antigens. This method does not require expensive medical
instruments and consumables. After adding the
extracted specimen to the sample well on the test cassette,
Cov*9, Influenza A/B virus antigens in the sample
will interact with the colloidal gold-labeled anti-SARS-CoV*2 and
Influenza A/B antibodies on the
conjugate pads. Then the conjugate pad will release
re-solubilized conjugate onto the nitrocellulose
membrane. The nitrocellulose membrane (NC membrane) diffuses it
forward.
Â
As the sample moves
along the device binding reagents situated on the nitrocellulose
membrane bind to the target at the test line. If
the sample contains a COV*9 antigen, it will bind to the
colloidal goldanti-SARS-CoV*2 Np monoclonal antibody,
diffuse forward, and then react with the anti-SARS-CoV*2 Np
monoclonal antibody immobilized on the NC
membrane detection line (COV*9 Test line). Similarly, if the
specimen contains Influenza A/Influenza B
antigens, the antigens will react with antibody-coated particles,
the conjugate migrate laterally forward, and
cause a colored lines (A, B linesrespectively).
Â
On the contrary, if
there is no Cov*9, Influenza A/B virus antigen in the sample or
the concentration of the antigens is below the
minimum detection limit, there is no colored lines in the test
area and the result is considered to be
negative.
Â
As a procedure control,
there is a quality control line (C line), this line will always
appear in the control line region, indicating that
the proper volume of specimen has been added and membrane wicking
has occurred, otherwise the test
result is invalid.
Â
Â
| Pays: |
China |
| N ° de modèle: |
-
|
| Prix FOB: |
( Negotiable ) (Negotiable)
Obtenir le dernier prix
|
| Localité: |
- |
| Prix de commande minimale: |
- |
| Commande minimale: |
100 Piece |
| Packaging Detail: |
- |
| Heure de livraison: |
- |
| Capacité de Fournir: |
1000000 Piece per Day |
| Payment Type: |
T/T, L/C |
| Groupe de produits : |
- |
